Intellectual Property India Publishes Patent Application for 'Anti-Trem1 Antibody Agents, Compositions, And Uses Thereof' Filed by Celsius Therapeutics, Inc.

MUMBAI, India, Feb. 21 -- Intellectual Property India has published a patent application (202517001492 A) filed by Celsius Therapeutics, Inc., Cambridge, U.S.A., on Jan. 7, for 'anti-trem1 antibody agents, compositions, and uses thereof.'

Inventor(s) include Bsat, Marwa; Fiallo, Juan Lopez; Guo, Siyang; Honig, Gerard Stefan; Johnson, Kristen; Li, Ping; L'Italien, Lawrence; Magram, Jeanne; Stransky, Nicolas; Varma, Mukund Madhav; Wiltzius, Stephanie; and Zuerndorfer, Sarah.

The application for the patent was published on Feb. 21, under issue no. 08/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are antibody agents that bind specifically to TREM1, nucleic acids encoding the same, compositions ...